Mar 4 |
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
|
Feb 21 |
OptimizeRx to Participate in Upcoming Investor Conferences
|
Feb 13 |
Bruker (BRKR) Q4 Earnings and Revenues Top Estimates
|
Jan 25 |
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
|
Jan 9 |
OptimizeRx says preliminary 2023 revenue expected to exceed previously announced guidance range of $68-$70M
|
Jan 9 |
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
|
Dec 26 |
Should You Exit OptimizeRx Corp. (OPRX)?
|
Dec 18 |
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
|
Dec 11 |
OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?
|
Dec 11 |
With 74% institutional ownership, OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst the big guns
|